|Committee Member||Employment||Consultant||Speaker’s Bureau||Ownership/ Partnership/ Principal||Personal Research||Institutional, Organizational, or Other Financial Benefit||Expert Witness|
|Brahmajee K. Nallamothu, Co-Chair||Ann Arbor VAMC Center for Clinical Management Research University of Michigan—Associate Professor||None||None||None|
|Carl L. Tommaso, Co-Chair||NorthShore University HealthSystem—Associate Professor, Rush Medical College Physician||None||None||None||None||None||None|
|H. Vernon Anderson||University of Texas Health Science Center–Houston—Professor, Department of Medicine||None||None||None||None|
|Jeffrey L. Anderson§||Intermountain Medical Center—Associate Chief of Cardiology||None||None||None||None|
|Joseph C. Cleveland, Jr.||University of Colorado at Denver—Professor of Surgery and Surgical Director, Cardiac Transplant and MCS||None||None||None||None||None|
|R. Adams Dudley||Institute for Health Policy Studies—Professor of Medicine and Health Policy||None||None||None||None||None||None|
|Peter Louis Duffy||FirstHealth of the Carolinas—Medical Director, Cardiovascular Service Line at Reid Heart Center, Interventional Cardiology||None||None||None||None|
|David P. Faxon||Brigham and Women’s Hospital—Vice Chair of Medicine, Cardiology||None||None||None|
|Hitinder S. Gurm||University of Michigan Cardiovascular Center—Associate Professor||None||None||None||None||None|
|Lawrence A. Hamilton||Kaiser Permanente, Northern California—Regional Director, Cardiac and Renal Services||None||None||None||None||None||None|
|Neil C. Jensen||United Healthcare—Director, Cardiology Network||None||None||None||None||None||None|
|Richard A. Josephson||University Hospitals of Cleveland Medical Group—Professor of Medicine, Case Western Reserve University School of Medicine||None||None||None||None||None||None|
|David J. Malenka||Dartmouth-Hitchcock Medical Center—Professor of Medicine, Division of Cardiology||None||None||None||None|
|Calin V. Maniu||Bon Secours Health System, Suffolk, Virginia—Physician||None||None||None||None||None||None|
|Kevin W. McCabe||S.C. Johnson & Son, Inc.—Director of Occupational and Preventive Medicine||None||None||None||None||None||None|
|James D. Mortimer||Jim Mortimer Consulting—Consultant||None||None||None||None||None||None|
|Manesh R. Patel||Duke University Medical Center—Assistant Professor of Medicine||None||None||None||None||None|
|Stephen D. Persell||Feinberg School of Medicine, Northwestern University—Assistant Professor of Medicine||None||None||None||None||None||None|
|John S. Rumsfeld¶||U.S. Veterans Health Administration—National Director of Cardiology; Chief Science Officer, National Cardiovascular Data Registry||None||None||None||None||None|
|Kendrick A. Shunk||San Francisco VA Medical Center—Director of Interventional Cardiology||None||None||None|
|Sidney C. Smith, Jr.||University of North Carolina at Chapel Hill—Professor of Medicine||None||None||None||None||None||None|
|Stephen J. Stanko||The Mended Hearts, Inc.—National Cath Patient Outreach Chair||None||None||None||None||None||None|
|Brook Watts||Louis Stokes Cleveland VA Medical Center—Associate Professor of Medicine, Case Western Reserve University||None||None||None||None||None||None|
This table represents the relationships of committee members with industry and other entities that were determined to be relevant to this document. These relationships were reviewed and updated in conjunction with all meetings and/or conference calls of the writing committee during the document development process. The table does not necessarily reflect relationships with industry at the time of publication. A person is deemed to have a significant interest in a business if the interest represents ownership of ≥5% of the voting stock or share of the business entity, or ownership of ≥$10,000 of the fair market value of the business entity; or if funds received by the person from the business entity exceed 5% of the person’s gross income for the previous year. Relationships that exist with no financial benefit are also included for the purpose of transparency. Relationships in this table are modest unless otherwise noted.
According to the ACC/AHA, a person has a relevant relationship IF: a) The relationship or interest relates to the same or similar subject matter, intellectual property or asset, topic, or issue addressed in the document; or b) The company/entity (with whom the relationship exists) makes a drug, drug class, or device addressed in the document, or makes a competing drug or device addressed in the document; or c) The person or a member of the person’s household, has a reasonable potential for financial, professional or other personal gain or loss as a result of the issues/content addressed in the document.
ACC indicates American College of Cardiology; AHA, American Heart Association; AMA-PCPI, American Medical Association–Physician Consortium for Performance Improvement; BCBS, Blue Shield Blue Cross; DCRI, Duke Clinical Research Institute; DSMB, Data Safety Monitoring Board; NCQA, National Committee for Quality Assurance; SCAI, Society for Cardiovascular Angiography and Interventions; VA, Veterans Affairs.
↵∗ At the time that this committee was convened, third-party payers were not deemed relevant.
↵† Dr. Nallamothu's relationship with Abbott Vascular (attended training for MitraClip) was added shortly before finalization of the performance measures, so it was not relevant during the development of the measures.
↵‡ No financial relationship.
↵§ Recused from voting on measure 7.
↵‖ Significant (greater than $10,000) relationship.
↵¶ Recused from voting on measures 9 and 11.